4 results  1 of 1 

1 Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
Intest Res.2022;20(2):203-212.   Published online 2022 April 29     DOI: http://dx.doi.org/10.5217/ir.2021.00020
      
2 Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients
Eul Sik Jung, Wookyung Chung, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Ji Yong Jung
J Korean Med Sci.2017;32(1):54-59.   Published online 2016 November 24     DOI: http://dx.doi.org/10.3346/jkms.2017.32.1.54
      
3 S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever
Ali Taylan, Oguz Gurler, Burak Toprak, Ali Riza Sisman, Hulya Yalcin, Ayfer Colak, Ismail Sari
J Korean Med Sci.2015;30(9):1241-1245.   Published online 2015 August 13     DOI: http://dx.doi.org/10.3346/jkms.2015.30.9.1241
      
4 Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study
Eun Chun Han, Sung Bin Cho, Keun Jae Ahn, Sang Ho Oh, Jihyun Kim, Dong Soo Kim, Kwang Hoon Lee, Dongsik Bang
Ann Dermatol.2011;23(3):313-320.   Published online 2011 August 6     DOI: http://dx.doi.org/10.5021/ad.2011.23.3.313
      

 1 of 1